
TechCrunch Industry News
Moderna claims 94% efficacy for COVID-19 vaccine, will ask FDA for emergency use authorization today
5 min•30 november 2020
Om avsnittet
Drugmaker Moderna has completed its initial efficacy analysis of its COVID-19 vaccine from the drug’s Phase 3 clinical study, and determined that it was 94.1% effective in preventing people from contracting COVID-19 across 196 confirmed cases from among 30,000 participants in the study. Moderna also found that it was 100% effective in preventing severe cases […]
Learn more about your ad choices. Visit podcastchoices.com/adchoices
Fler avsnitt
Visa alla avsnitt av TechCrunch Industry NewsTechCrunch Industry News med TechCrunch finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.